I70.2
Conditions
Interventions
Group 1: Prospective single-arm analysis of patients with symptomatic peripheral arterial occlusive disease who undergo catheter intervention between May and September 2024 to improve blood flow. Pati
Sponsors
Interdisziplinäres Gefäßzentrum des Universitätsklinikums Mannheim
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Rutherford clinical category 2 – 5 with clinical indications for revascularisation Capable of giving consent and written informed consent to participate in the study
Exclusion criteria
Exclusion criteria: acute systemic or foot infection severe heart failure limb edema No possibility of adequate placement of the measuring probe (e.g., due to skin defects, pain)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoints were the intraprocedural microcirculatory parameter SO2, Flow and rHb at maximum, at the end of the procedure and the next day compared to baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints were the ABI shift and the Rutherford category shift (difference between follow-up as compared to baseline). | — |
Countries
Germany
Contacts
Public ContactMartin Sigl
Interdisziplinäres Gefäßzentrum des Universitätsklinikums Mannheim
Outcome results
None listed